Unicorn Fund

Unicorn Fund reduced its stake in Accretion Nutraveda Limited from 6.59% to 5.69%, selling 65,000 shares for ₹1.68 crore at ₹259.30 apiece.

Unicorn Fund acquired 3,07,200 shares, representing a 2.76% stake in Accretion Pharmaceuticals, for ₹4.77 crore at ₹155.50 per share.

Unicorn Fund bought 93,089 shares of Trustedge Capital Limited, a 1.01% stake, for ₹1.33 Cr at ₹143.80 apiece.

Unicorn Fund bought 49,015 shares of Trustedge Capital Limited for ₹0.57 Cr at ₹117.11 apiece in a bulk deal on June 24, 2026.

Unicorn Fund bought 67,200 shares of Accretion Pharmaceuticals for ₹69 lakh at ₹102.60 apiece in a bulk deal on April 29, 2026.

Unicorn Fund bought 477,000 shares of Accretion Nutraveda Limited for ₹10.73 Cr at ₹225.00 apiece through a public issue, crossing the 5% disclosure threshold.

Unicorn Fund sold 5,43,896 shares of Shree Ram Twistex for ₹3.70 Cr at ₹68.00 apiece in a bulk deal.